Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6478-6487

  Dalli, Jesmond ^a   Consalvo, Angelo P ^b   Ray, Vicki ^b   Filippo, Clara Di ^c   D'Amico, Michele ^c   Mehta, Nozer ^b   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Unigene Laboratories Incorporated   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; LEUKOCYTE ELASTASE; LIPOCORTIN 1; MYELOBLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CARDIOVASCULAR MORTALITY; CELL INTERACTION; CELLULAR PARAMETERS; DISEASE MODEL; DRUG RECEPTOR BINDING; EFFEROCYTOSIS; ENDOTHELIUM CELL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INCIDENCE; KNOCKOUT MOUSE; LEUKOCYTE ADHERENCE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN ENGINEERING; PROTEIN STABILITY; REPERFUSION INJURY; VENULE; WILD TYPE;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NEUTROPHILS; PEPTIDES; PHAGOCYTOSIS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 84879091724     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203000     Document Type: Article

References (44)

1. Serhan, C. N., S. D. Brain, C. D. Buckley, D. W. Gilroy, C. Haslett, L. A. O'Neill, M. Perretti, A. G. Rossi, and J. L. Wallace. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21: 325-332. (Pubitemid 46213480)
2. Serhan, C. N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6: 1191-1197. (Pubitemid 43045627)
3. Nathan, C., and A. Ding. 2010. Nonresolving inflammation. Cell 140: 871-882.
4. Hayhoe, R. P., A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti. 2006. Annexin 1 and its bioactive peptide inhibit neutrophil- endothelium interactions under flow: indication of distinct receptor involvement. Blood 107: 2123-2130. (Pubitemid 43289398)
5. D'Amico, M., C. Di Filippo, M. La, E. Solito, P. G. McLean, R. J. Flower, S. M. Oliani, and M. Perretti. 2000. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J. 14: 1867- 1869.
6. El Kebir, D., L. József, T. Khreiss, W. Pan, N. A. Petasis, C. N. Serhan, and J. G. Filep. 2007. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 179: 616-622. (Pubitemid 46986579)
7. Maderna, P., S. Yona, M. Perretti, and C. Godson. 2005. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J. Immunol. 174: 3727-3733. (Pubitemid 40354084)
8. Solito, E., S. McArthur, H. Christian, F. Gavins, J. C. Buckingham, and G. E. Gillies. 2008. Annexin A1 in the brain - undiscovered roles? Trends Pharmacol. Sci. 29: 135-142.
9. Paschalidis, N., A. J. Iqbal, F. Maione, E. G. Wood, M. Perretti, R. J. Flower, and F. D'Acquisto. 2009. Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1. J. Neuroinflammation 6: 33.
10. Gavins, F. N., J. Dalli, R. J. Flower, D. N. Granger, and M. Perretti. 2007. Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J. 21: 1751-1758. (Pubitemid 46855621)
11. Ayoub, S. S., S. Yazid, and R. J. Flower. 2008. Increased susceptibility of annexin-A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin-A1. Br. J. Pharmacol. 154: 1135-1142. (Pubitemid 351915065)
12. Vong, L., J. G. Ferraz, N. Dufton, R. Panaccione, P. L. Beck, P. M. Sherman, M. Perretti, and J. L. Wallace. 2012. Up-regulation of Annexin-A1 and lipoxin A (4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS ONE 7: e39244.
13. Perretti, M., N. Chiang, M. La, I. M. Fierro, S. Marullo, S. J. Getting, E. Solito, and C. N. Serhan. 2002. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8: 1296-1302. (Pubitemid 35373563)
14. Krishnamoorthy, S., A. Recchiuti, N. Chiang, S. Yacoubian, C. H. Lee, R. Yang, N. A. Petasis, and C. N. Serhan. 2010. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. USA 107: 1660-1665.
15. Vong, L., F. D'Acquisto, M. Pederzoli-Ribeil, L. Lavagno, R. J. Flower, V. Witko-Sarsat, and M. Perretti. 2007. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J. Biol. Chem. 282: 29998-30004. (Pubitemid 350035249)
16. Rescher, U., V. Goebeler, A. Wilbers, and V. Gerke. 2006. Proteolytic cleavage of annexin 1 by human leukocyte elastase. Biochim. Biophys. Acta 1763: 1320-1324. (Pubitemid 44779860)
17. La, M., A. Tailor, M. D'Amico, R. J. Flower, and M. Perretti. 2001. Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: focus on neutrophil recruitment. Eur. J. Pharmacol. 429: 263-278. (Pubitemid 33044001)
18. Pupjalis, D., J. Goetsch, D. J. Kottas, V. Gerke, and U. Rescher. 2011. Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling. EMBO Mol. Med. 3: 102-114.
19. Perretti, M., and J. Dalli. 2009. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br. J. Pharmacol. 158: 936-946.
20. Dalli, J., T. Montero-Melendez, S. McArthur, and M. Perretti. 2012. Annexin A1 N-terminal derived Peptide ac2-26 exerts chemokinetic effects on human neutrophils. Front Pharmacol 3: 28.
21. Ernst, S., C. Lange, A. Wilbers, V. Goebeler, V. Gerke, and U. Rescher. 2004. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J. Immunol. 172: 7669-7676. (Pubitemid 38747633)
22. Ray, M. V., C. P. Meenan, A. P. Consalvo, C. A. Smith, D. P. Parton, A. M. Sturmer, P. P. Shields, and N. M. Mehta. 2002. Production of salmon calcitonin by direct expression of a glycine-extended precursor in Escherichia coli. Protein Expr. Purif. 26: 249-259. (Pubitemid 35326543)
23. Dalli, J., L. V. Norling, D. Renshaw, D. Cooper, K. Y. Leung, and M. Perretti. 2008. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood 112: 2512-2519.
24. Dufton, N., R. Hannon, V. Brancaleone, J. Dalli, H. B. Patel, M. Gray, F. D'Acquisto, J. C. Buckingham, M. Perretti, and R. J. Flower. 2010. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. 184: 2611-2619.
25. Perretti, M., S. J. Getting, E. Solito, P. M. Murphy, and J. L. Gao. 2001. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am. J. Pathol. 158: 1969-1973. (Pubitemid 32545181)
26. Chatterjee, B. E., S. Yona, G. Rosignoli, R. E. Young, S. Nourshargh, R. J. Flower, and M. Perretti. 2005. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J. Leukoc. Biol. 78: 639-646. (Pubitemid 41292086)
27. Gavins, F. N., A. M. Kamal, M. D'Amico, S. M. Oliani, and M. Perretti. 2005. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J. 19: 100-102. (Pubitemid 40069931)
28. Perretti, M., and F. D'Acquisto. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9: 62-70.
29. Bannenberg, G. L., N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K. H. Gotlinger, S. Hong, and C. N. Serhan. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174: 4345-4355. (Pubitemid 40396017)
30. El Kebir, D., L. József, and J. G. Filep. 2008. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. J. Leukoc. Biol. 84: 600-606.
31. Eltzschig, H. K., and T. Eckle. 2011. Ischemia and reperfusion - from mechanism to translation. Nat. Med. 17: 1391-1401.
32. Blume, K. E., S. Soeroes, H. Keppeler, S. Stevanovic, D. Kretschmer, M. Rautenberg, S. Wesselborg, and K. Lauber. 2012. Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic "find-me" signal. J. Immunol. 188: 135-145.
33. Witko-Sarsat, V., N. Reuter, and L. Mouthon. 2010. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis. Curr. Opin. Rheumatol. 22: 1-7.
34. Fischer, B. M., S. Zheng, R. Fan, and J. A. Voynow. 2007. Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L762-L768. (Pubitemid 47358839)
35. Pederzoli-Ribeil, M., F. Maione, D. Cooper, A. Al-Kashi, J. Dalli, M. Perretti, and F. D'Acquisto. 2010. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood 116: 4288-4296.
36. Rosengarth, A., and H. Luecke. 2003. A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J. Mol. Biol. 326: 1317-1325. (Pubitemid 36269076)
37. Dufton, N., J. Natividad, E. F. Verdu, and J. L. Wallace. 2012. Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe. Sci. Rep. 2: 499.
38. Rossi, A. G., D. A. Sawatzky, A. Walker, C. Ward, T. A. Sheldrake, N. A. Riley, A. Caldicott, M. Martinez-Losa, T. R. Walker, R. Duffin, et al. 2006. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. [Published erratum appears in 2006 Nat. Med. 12: 1434.] Nat. Med. 12: 1056-1064. (Pubitemid 44353387)
39. 4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. USA 109: 935-940.
40. Ioannou, A., J. Dalle Lucca, and G. C. Tsokos. 2011. Immunopathogenesis of ischemia/reperfusion-associated tissue damage. Clin. Immunol. 141: 3-14.
41. Qiu, F. H., K. Wada, G. L. Stahl, and C. N. Serhan. 2000. IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment. Proc. Natl. Acad. Sci. USA 97: 4267-4272. (Pubitemid 30226122)
42. Ritchie, R. H., J. M. Gordon, O. L. Woodman, A. H. Cao, and G. J. Dusting. 2005. Annexin-1 peptide Anx-1(2-26) protects adult rat cardiac myocytes from cellular injury induced by simulated ischaemia. Br. J. Pharmacol. 145: 495-502. (Pubitemid 40966279)
43. Ritchie, R. H., X. Sun, J. L. Bilszta, L. M. Gulluyan, and G. J. Dusting. 2003. Cardioprotective actions of an N-terminal fragment of annexin-1 in rat myocardium in vitro. Eur. J. Pharmacol. 461: 171-179. (Pubitemid 36174035)
44. Bena, S., V. Brancaleone, J. M. Wang, M. Perretti, and R. J. Flower. 2012. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J. Biol. Chem. 287: 24690-24697.